Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COL-5671-PRO in Adult Participants With Moderate-to-Severe Plaque Psoriasis
NCT07914231Phase 2Not yet recruiting
- Sponsor
- Coultreon Biopharma
- Start
- Oct 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of COL-5671 in plaque psoriasis, sponsored by Coultreon Biopharma. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
COL-5671
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07914231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07914231.